OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Cardiovascular Drugs
DOI: 10.1007/s40256-015-0146-z
Authors: Stephen J. Nicholls, Rishi Puri, Kathy Wolski, Christie M. Ballantyne, Philip J. Barter, H. Bryan Brewer, John J. P. Kastelein, Bo Hu, Kiyoko Uno, Yu Kataoka, Jean-Paul R. Herrman, Bela Merkely, Marilyn Borgman, Steven E. Nissen
Institutions: South Australian Health and Medical Research Institute, Cleveland Clinic, Baylor College of Medicine, UNSW Sydney, MedStar Health Research Institute, Amsterdam UMC Location University of Amsterdam, OLVG, Semmelweis University
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: coronary artery disease, atherosclerotic plaque progression, low HDL cholesterol, apolipoprotein A-I, LDL cholesterol, intravascular ultrasound, liver enzymes, drug safety, RVX-208, ASSURE trial, lipoprotein metabolism, inflammation in atherosclerosis, hypertriglyceridemia
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2234034631
FWCI: 7.789
Cites: 29
Cited by: 112
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security